New Healixia logo
Search
Search
Radisson Hotel Antwerp Berchem

Healixia symposium: Strengthening the landscape for Early Phase clinical studies in Belgium

Join us for an insightful afternoon.

Now open for registration!

  1. -

    • Registration

  2. -

    • Welcome & introduction with pre-symposium survey results

  3. -

    • The impact of EU-CTR on clinical vaccine research in Belgium by Isabel Leroux-Roels (UZ Gent)

    • Early phase studies with genetically modified (GMO) vaccines, a case study by Bruno Speder (AstriVax)

  4. -

    • Early phase achievements & proposed improvements from regulatory perspective by Katelijne Anciaux (CT College)

    • How to consolidate Belgium as an early clinical trial hub: challenges and opportunities in an evolving landscape by Nathalie Lambot (pharma.be)

  5. -

    • Panel discussion

  6. -

    • Coffee break

  7. -

    • Modus operandus and role of BAREC in the Belgian landscape by Pieter Moons (BAREC)

  8. -

    • Data transparancy rules from regulatory perspective by Nele Steens (FAMHP)

    • EU Clinical Trial Regulation and Data Transparency: Implications for protecting our Innovation by Maarten Timmers (Johnson & Johnson)

    • Panel discussion

  9. -

    • CTR and academic research by Minne Casteels & Ruth Storme (KU Leuven)

  10. -

    • Symposium wrap-up

  11. -

    • Closing drink

Back to overview

Schedule of Healixia symposium: Strengthening the landscape for Early Phase clinical studies in Belgium